Loading clinical trials...
Loading clinical trials...
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception: Randomised Controlled Trial
Conditions
Interventions
Piroxicam 40 mg
Levonorgestrel 1.5mg
Locations
2
Hong Kong
Queen Mary Hospital
Hong Kong, Hong Kong
The Family Planning Association of Hong Kong
Hong Kong, Hong Kong
Start Date
August 20, 2018
Primary Completion Date
October 5, 2022
Completion Date
October 5, 2022
Last Updated
May 6, 2024
NCT06162611
NCT02078414
NCT03395756
NCT04172584
NCT01569737
NCT01569113
Lead Sponsor
Dr. Hang Wun Raymond Li
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions